MedPath

Study of a Home Delivered Meal Program on Obese Elderly African American Subjects With Type 2 Diabetes Mellitus (DM)

Not Applicable
Terminated
Conditions
Obesity
Diabetes
Registration Number
NCT00743756
Lead Sponsor
Emory University
Brief Summary

The purpose of this study is to assess the impact of home-delivered Medical Nutrition Therapy on clinical outcomes for persons with diabetes. The primary outcomes of this studies include A1c (A1C), blood glucose, blood pressure, Body Mass Index, lipid levels and other measures of disease progression and management as well as costs of medical care provided throughout the intervention period.

Detailed Description

Data collected as a result of this project will be evaluated in aggregate to demonstrate the potential impacts on health and medical costs available through this type of intervention, with long-term goals of reducing disability and deaths due to chronic disease.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
38
Inclusion Criteria
  1. African-American subjects
  2. Males or females 65 - 85 years of age
  3. Body mass index (BMI) equal to or greater than 30 kg/m2
  4. Fasting blood glucose less than 300 mg/dL and HbA1c less than 9.0%
  5. Ability to understand and be willing to adhere to the study protocol
  6. A known history of type 2 diabetes mellitus greater than 3 months, receiving either diet alone or oral antidiabetic agents (sulfonylureas, metformin, thiazolidinediones).
Exclusion Criteria
  1. Subjects with a history of diabetic ketoacidosis and hyperosmolar hyperglycemic state.
  2. Patients with clinically relevant hepatic disease or impaired renal function, as shown by a serum creatinine greater than 3.0 mg/dL.
  3. Mental condition rendering the subject unable to understand the scope of the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Weight Loss in the elderly african american population6 months to 1 year
Secondary Outcome Measures
NameTimeMethod
Endothelial Function (assessed by pulse-wave analysis); sympathetic activity; insulin sensitivity6 months to 1 year

Trial Locations

Locations (1)

Grady Health System

🇺🇸

Atlanta, Georgia, United States

Grady Health System
🇺🇸Atlanta, Georgia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.